Last week, a globally active, privately held, mid-sized contract research organization (CRO) claims its research site is the very first one to dose a subject…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.